Genetic engineering & bio-selection

01Overview and value chain#

Markers EC: GMO Directive 2001/18/EC | OECD: agri-biotech | Regulator: USDA-APHIS (USA), EFSA (EU), MOA-China (China)

Genetic engineering and bio-selection are transforming global agriculture by accelerating the development of resilient, high-yielding crop varieties.

1. Genomic selection to rapidly identify elite breeding lines.
2. CRISPR-Cas9 multiplex editing for complex polygenic traits.
3. Marker-assisted breeding to bypass lengthy field trials.
4. RNA interference (RNAi) traits for built-in pest resistance.

Value chain levels#

┌──────────────────────────────────────────────────────────────────────────────┐
│                  Germplasm sequencing and trait discovery                    │
└──────────────────────────────────────────────────────────────────────────────┘
                                       │
                                       ▼
┌──────────────────────────────────────────────────────────────────────────────┐
│               Gene editing (CRISPR) or Marker-Assisted Selection             │
└──────────────────────────────────────────────────────────────────────────────┘
                                       │
                                       ▼
┌──────────────────────────────────────────────────────────────────────────────┐
│                    Greenhouse and field trial validation                     │
└──────────────────────────────────────────────────────────────────────────────┘
                                       │
                                       ▼
┌──────────────────────────────────────────────────────────────────────────────┐
│                Commercial seed multiplication and distribution               │
└──────────────────────────────────────────────────────────────────────────────┘

Cross-cutting technologies of the sector:

• Genomic selection: Using whole-genome models to predict plant performance.
• Multiplex CRISPR editing: Modifying multiple genes simultaneously.
• Speed breeding: Extending photoperiods to achieve multiple generations per year.

02US#

The US leads the global market in commercializing genetically engineered crops, driven by major ag-tech hubs.

Commercialization and Innovation#

Companies like Corteva and Inari leverage predictive AI and multiplex gene editing to create next-generation seeds. The USDA APHIS SECURE rule provides a favorable regulatory pathway, exempting many CRISPR-edited crops from the stringent regulations that govern traditional transgenics.

03CN#

China aggressively pursues genetic engineering to ensure national food security and reduce reliance on seed imports.

Strategic Seed Security#

Syngenta (under ChemChina) and national academies focus on developing high-yield, drought-resistant varieties of rice, wheat, and soybeans. Recent regulatory shifts by the MOA-China have cleared the path for commercial planting of bio-engineered crops, scaling up national bio-selection programs.

04EU#

The EU has historically maintained strict GMO regulations but is currently adapting its framework for New Genomic Techniques (NGTs).

NGTs and Sustainable Farming#

European companies like Bayer Crop Science and KeyGene focus strongly on marker-assisted selection and NGTs. While traditional transgenics face heavy restrictions, the EU’s evolving stance on CRISPR-edited crops aims to support the Green Deal’s goals of reducing chemical pesticide use through inherent crop resilience.

05Leading companies and research institutes#

06Tech stack and innovations#

1. Multiplex Editing: Using advanced CRISPR systems to simultaneously alter dozens of genetic loci, optimizing complex traits like water-use efficiency.
2. Speed Breeding: Combining customized LED lighting algorithms and precise temperature control to accelerate the plant growth cycle.

07Value chains and production pipelines#

Seed Bio-Selection Pipeline#

┌──────────────┐      ┌──────────────┐
│ 1. AI Design │ ───> │ 2. Editing   │
└──────────────┘      └──────────────┘
                             │
                             ▼
┌──────────────┐      ┌──────────────┐
│ 4. Hardening │ <─── │ 3. Tissue Cul│
└──────────────┘      └──────────────┘
       │
       ▼
┌──────────────┐      ┌──────────────┐
│ 5. Nursery   │ ───> │ 6. Retail    │
└──────────────┘      └──────────────┘

Stage 1:

Computational identification of genes associated with the desired trait.

Stage 2:

Agrobacterium-mediated transformation or CRISPR-Cas9 delivery.

Stage 3:

Regeneration of whole plants from single edited cells via in vitro tissue culture.

Stage 4:

Acclimatization and hardening of plantlets in high-humidity growth chambers.

Stage 5:

Scale-up cultivation in automated, climate-controlled commercial greenhouses.

Stage 6:

Distribution to B2B landscaping firms or direct-to-consumer retail sales.